Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04733235
Other study ID # AkdenizUKD
Secondary ID
Status Completed
Phase
First received
Last updated
Start date July 1, 2020
Est. completion date July 15, 2021

Study information

Verified date December 2022
Source Akdeniz University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purpose of this prospective cohort study is to assess the effect of endometrial compaction caused by progesterone effect on pregnancy outcomes


Description:

For a pregnancy to occur, the embryo must implant in a receptive endometrium during the window of implantation, which is thought to occur from day 22 to 24 of an idealized 28-day cycle. Early studies have suggested that assessing endometrial thickness with the use of ultrasound may be an alternative to invasive techniques such as endometrial biopsy for attempting to determine a receptive endometrium for frozen-thawed embryo transfer (FET). A preovulatory endometrial thickness of 7 mm or more is considered to be the cutoff for endometrial receptivity, below which many physicians would cancel an embryo transfer. However, in most studies in the literature, endometrial thickness was measured either on the day of hCG in fresh embryo transfer cases or on the last day of estrogen treatment in thawed embryo transfers. There are a limited number of studies evaluating the luteal period, embryo transfer day and endometrial thickness. Accordingly, in this prospective cohort study is to assess the effect of endometrial compaction caused by progesterone effect on pregnancy outcomes


Recruitment information / eligibility

Status Completed
Enrollment 205
Est. completion date July 15, 2021
Est. primary completion date April 15, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 40 Years
Eligibility Inclusion Criteria: 1. Woman aged 18-40 years 2. Presence of high quality (>2BB) blastocyst 3. Hormonal(estrogen and progesterone) frozen- thawed embryo transfer cycles 4. presence of high quality blastocyst cryopreserved by vitrification method. 5. A single embryo transfer Exclusion Criteria: 1. Presence of uterine pathology 2. Participants whose optimal endometrial image cannot be obtained due to uterine position 3. Participants whose treatments were canceled for any reason before embryo transfer 4. Participants which had embryo transfer on the day 2 or 3 (at the cleavage stage) 5. Participants who had 2 embryo transfer 6. Presence of low quality (<2BB) blastocyst 7. > 15% loss of viability in the embryo during embryo thawing

Study Design


Intervention

Drug:
Progesterone
ultrasound measurements of endometrial thickness at the end of the estrogen phase and the day of embryo transfer.

Locations

Country Name City State
Turkey Akdeniz University Antalya

Sponsors (1)

Lead Sponsor Collaborator
Akdeniz University

Country where clinical trial is conducted

Turkey, 

References & Publications (1)

Haas J, Smith R, Zilberberg E, Nayot D, Meriano J, Barzilay E, Casper RF. Endometrial compaction (decreased thickness) in response to progesterone results in optimal pregnancy outcome in frozen-thawed embryo transfers. Fertil Steril. 2019 Sep;112(3):503-5 — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary The change in endometrial thickness changing in millimeters of endometrial thickness at the end of the estrogen phase and the day of embryo transfer. 1 year
Primary ongoing pregnancy rates. pregnancy beyond 12 weeks of gestational age. 1 year
Secondary The Correlation of Serum Progesterone Levels With the Degree of Endometrial Compaction on the Day of Frozen Embryo Transfer comparison of progesterone levels and endometrial thickness On the day of frozen embryo transfer
Secondary Clinical pregnancy rate 6th week gestational age 6-7 weeks after the last menstrual period of the patient
Secondary Implantation rate Percentage of gestational sacs compared to the number of embryos transferred 5 weeks after the last menstrual period of the patient
Secondary Clinical miscarriage pregnancy loss after ultrasonographic detection of an intrauterine gestational sac after 5th gestational week
See also
  Status Clinical Trial Phase
Completed NCT03607409 - Role of Inhibin A as Biomarker for Ovarian Response for IVF Treatment
Recruiting NCT02312076 - GnRHa for Luteal Phase Support in Long GnRHa Protocol Cycles Phase 4
Terminated NCT02161861 - Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study N/A
Completed NCT03287479 - Comparison of a Semi-automated Closed Vitrification System (Gavi®) With a Manual Open Vitrification Sytem (Cryotop®) N/A
Terminated NCT03522350 - Randomized Trial Comparing EmbryoScope With EmbryoScope+. N/A
Completed NCT04496284 - Embryo Transfer Outcomes After Vitrification With Slush Nitrogen Compared to Liquid Nitrogen N/A
Completed NCT03623659 - pArtiaL zonA pelluciDa Removal by assisteD hatchINg of Blastocysts N/A
Completed NCT03895099 - New Ovarian Stimulation With Random Start, Use of Progestin Protocol for Oocyte Donors Phase 3
Active, not recruiting NCT04142112 - Randomized, Standard-Controlled, Study to Evaluate the Ohana IVF Sperm Preparation Kit, SPeRtility IVF Next Generation N/A
Completed NCT03152643 - Cumulative Live Birth Rates After Cleavage-stage Versus Blastocyst-stage Embryo Transfer N/A
Recruiting NCT03683771 - Assessment of Endometrial Pattern and Sub-endometrial Vascularity in ICSI Outcome
Recruiting NCT03161119 - Comparing Two Different Embryo Transfer Catheters N/A
Completed NCT04108039 - Micronized Progesterone vs Gonadotropin-releasing Hormone (GnRH) Antagonist in Freeze-all IVF Cycles. N/A
Completed NCT03678558 - Oocyte Vitrification Aided With Cytochalasin B N/A
Completed NCT03678571 - Oocyte Vitrification Aided With Latrunculin A N/A
Completed NCT03678597 - Supplementing Intracytoplasmic Sperm Injection Handling Medium With Latrunculin B ( ICSI-LB) N/A
Completed NCT03678584 - Supplementing Intracytoplasmic Sperm Injection Handling Medium With Chaetoglobosin A ( ICSI-CA) N/A
Completed NCT03677492 - Supplementing Intracytoplasmic Sperm Injection Handling Medium With Cytochalasin D ( ICSI-CD) N/A
Completed NCT03678610 - Handling Medium for ICSI With Ionomycin and Latrunculin A N/A
Completed NCT03678818 - Supplementing Intracytoplasmic Sperm Injection Handling Medium With Latrunculin A (ICSI-LA) N/A